PH+ ALL
Clinical trials for PH+ ALL explained in plain language.
Never miss a new study
Get alerted when new PH+ ALL trials appear
Sign up with your email to follow new studies for PH+ ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to tame aggressive leukemia with fewer side effects
Disease control Recruiting nowThis study is for people newly diagnosed with a specific type of leukemia called Ph+ ALL. It tests a treatment plan that uses lower doses of chemotherapy along with targeted drugs (venetoclax, blinatumomab, and olverembatinib) to see if it works well and causes fewer side effects…
Matched conditions: PH+ ALL
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 17, 2026 01:46 UTC
-
New hope for leukemia patients: phase 3 trial of olverembatinib combo launches
Disease control Recruiting nowThis phase 3 trial tests whether a new targeted drug (olverembatinib) combined with chemotherapy works better than other standard targeted drugs plus chemotherapy for adults newly diagnosed with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). About 350 pa…
Matched conditions: PH+ ALL
Phase: PHASE3 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated May 14, 2026 12:03 UTC